SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001626199-22-000050
Filing Date
2022-06-21
Accepted
2022-06-21 16:39:17
Documents
12
Period of Report
2022-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K alpn-20220616.htm   iXBRL 8-K 44512
  Complete submission text file 0001626199-22-000050.txt   185280

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alpn-20220616.xsd EX-101.SCH 1951
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alpn-20220616_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alpn-20220616_pre.xml EX-101.PRE 13082
6 EXTRACTED XBRL INSTANCE DOCUMENT alpn-20220616_htm.xml XML 11285
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 221028648
SIC: 2834 Pharmaceutical Preparations